Unlock this StockReport nowClick to Unlock

2Valorise NV

VALOR €5.95 0.0  0.0%
11:05am

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
12m Forecast Rolling
PE Ratio (ttm) 35.1
PEG Ratio (ttm)
EPS Growth (ttm) %
Dividend Yield (ttm) %
Valuation (ttm)
Price to Book Value 1.54
Price to Tang. Book
Price to Free Cashflow
Price to Sales
EV to EBITDA
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 TTM 2018E 2019E CAGR / Avg
Revenue €m
Operating Profit €m
Net Profit €m
EPS Reported
EPS Normalised
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc €m
Working Capital €m
Net Fixed Assets €m
Net Debt €m
Book Value €m
Average Shares m
Book Value ps

FINANCIAL BRIEF: For the six months ended 30 June 2018, 2Valorise NV revenues decreased 8% to EUR11.2M. Net income increased 36% to EUR773K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income reflects Other operating income increase from EUR16K to EUR2M (income), Other Operating Expenses decrease of 17% to EUR1.4M (expense). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 30th Jun '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2018
31st Dec 2019

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (€) (€) (€) (€) (€) (€)
Consensus Estimate
1m Change
3m Change
Broker Consensus Trend
Broker Recommendations for 2Valorise NV
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
There are no named brokers.

Profile Summary

2Valorise NV is a Belgium-based company engaged in the field of renewable energy. The Company develops and manages small and medium-sized projects that valorize biomass into energy. The Company’s business consists in turning non-contaminated wood biomass, which are at their end-of-life in the forestry sector, into energy, either directly through cogeneration to generate heat and electricity, or indirectly to produce renewable solid fuels, such as dried wood chips and white wood pellets. The Company has cogeneration projects located in Amel (Wallonia, Belgium). It thereby sells the created green certificates to energy suppliers. The Company operates through its subsidiaries, including Renogen SA, 4HamCogen NV and Amel Bio SA.

Directors: Filip Lesaffer (CEO) 41, Dirk Slegers (CFO) , Jean-Francois Meys (COO) , Guido Schockaert (CTO) 49, Yves Crits (NED) 51, Henri Meyers (NID) 69,

No. of Employees: 38 No. of Shareholders: n/a


Last Annual December 31st, 2017
Last Interim June 30th, 2018
Incorporated September 28, 2005
Public Since June 13, 2008
Shares in Issue 7,593,794
Free Float 445k (5.9%)
Sector Utilities
Industry Electric Utilities & IPPs
Index
Exchange Euronext - Brussels
Eligible for an ISA? a SIPP?

Address de Snep 3324, HAM, 3945, Belgium
Web http://www.2valorise.be
Phone +32 2 5269010
Contact ()
Auditors KPMG Bedrijfsrevisoren

VALOR Share Price Performance VALORQuote
€5.95
0.0  0.0%
Traded 11:05am · Minimum 15 min delayed · NMS:


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2018.


Should you buy VALOR

Access VALOR Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis